Clinical Trial Update: [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the PET imaging agent [18F]ISO-1 in primary breast cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [18F]ISO-1 ([18F]ISO-1)

Snippet

Sponsor: University of Pennsylvania | Conditions: Breast Cancer, Breast Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING